Bruker Corporation (BRKR)
USD 36.32
(-3.56%)
USD 36.32
(-3.56%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 427.2 Million USD | 44.03% |
| 2022 | 296.6 Million USD | 7.04% |
| 2021 | 277.1 Million USD | 75.6% |
| 2020 | 157.8 Million USD | -19.98% |
| 2019 | 197.2 Million USD | 9.74% |
| 2018 | 179.7 Million USD | 128.63% |
| 2017 | 78.6 Million USD | -48.83% |
| 2016 | 153.6 Million USD | 51.18% |
| 2015 | 101.6 Million USD | 79.19% |
| 2014 | 56.7 Million USD | -29.21% |
| 2013 | 80.1 Million USD | 3.35% |
| 2012 | 77.5 Million USD | -16.03% |
| 2011 | 92.3 Million USD | -3.25% |
| 2010 | 95.4 Million USD | 17.49% |
| 2009 | 81.2 Million USD | 25.12% |
| 2008 | 64.9 Million USD | 105.84% |
| 2007 | 31.52 Million USD | 70.6% |
| 2006 | 18.48 Million USD | 406.88% |
| 2005 | 3.64 Million USD | 146.56% |
| 2004 | -7.83 Million USD | 55.39% |
| 2003 | -17.55 Million USD | -183.13% |
| 2002 | -6.2 Million USD | -270.47% |
| 2001 | 3.63 Million USD | 61.64% |
| 2000 | 2.25 Million USD | 80.07% |
| 1999 | 1.24 Million USD | 0.0% |
| 1998 | - USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | 50.9 Million USD | -75.23% |
| 2024 Q3 | 40.9 Million USD | 438.16% |
| 2024 Q2 | 7.6 Million USD | -85.07% |
| 2023 Q2 | 57.1 Million USD | -25.36% |
| 2023 FY | 427.2 Million USD | 44.03% |
| 2023 Q1 | 76.5 Million USD | -21.46% |
| 2023 Q4 | 205.5 Million USD | 133.26% |
| 2023 Q3 | 88.1 Million USD | 54.29% |
| 2022 FY | 296.6 Million USD | 7.04% |
| 2022 Q1 | 61.6 Million USD | -18.63% |
| 2022 Q2 | 49.5 Million USD | -19.64% |
| 2022 Q3 | 88.1 Million USD | 77.98% |
| 2022 Q4 | 97.4 Million USD | 10.56% |
| 2021 FY | 277.1 Million USD | 75.6% |
| 2021 Q3 | 87.1 Million USD | 51.22% |
| 2021 Q2 | 57.6 Million USD | 1.59% |
| 2021 Q1 | 56.7 Million USD | -17.71% |
| 2021 Q4 | 75.7 Million USD | -13.09% |
| 2020 Q3 | 54.3 Million USD | 125.31% |
| 2020 FY | 157.8 Million USD | -19.98% |
| 2020 Q4 | 68.9 Million USD | 26.89% |
| 2020 Q2 | 24.1 Million USD | 129.52% |
| 2020 Q1 | 10.5 Million USD | -84.69% |
| 2019 FY | 197.2 Million USD | 9.74% |
| 2019 Q4 | 68.6 Million USD | 11.91% |
| 2019 Q1 | 30.8 Million USD | -60.56% |
| 2019 Q2 | 36.5 Million USD | 18.51% |
| 2019 Q3 | 61.3 Million USD | 67.95% |
| 2018 Q1 | 27 Million USD | 894.12% |
| 2018 Q2 | 31.2 Million USD | 15.56% |
| 2018 FY | 179.7 Million USD | 128.63% |
| 2018 Q4 | 78.1 Million USD | 79.95% |
| 2018 Q3 | 43.4 Million USD | 39.1% |
| 2017 Q1 | 21.6 Million USD | -68.7% |
| 2017 FY | 78.6 Million USD | -48.83% |
| 2017 Q3 | 37 Million USD | 58.12% |
| 2017 Q4 | -3.4 Million USD | -109.19% |
| 2017 Q2 | 23.4 Million USD | 8.33% |
| 2016 FY | 153.6 Million USD | 51.18% |
| 2016 Q4 | 69 Million USD | 48.39% |
| 2016 Q3 | 46.5 Million USD | 220.69% |
| 2016 Q2 | 14.5 Million USD | -38.56% |
| 2016 Q1 | 23.6 Million USD | -61.56% |
| 2015 Q3 | 11.8 Million USD | -46.12% |
| 2015 FY | 101.6 Million USD | 79.19% |
| 2015 Q4 | 61.4 Million USD | 420.34% |
| 2015 Q1 | 6.5 Million USD | -75.1% |
| 2015 Q2 | 21.9 Million USD | 236.92% |
| 2014 Q1 | 8.7 Million USD | -75.28% |
| 2014 Q3 | 5.5 Million USD | -66.46% |
| 2014 Q4 | 26.1 Million USD | 374.55% |
| 2014 FY | 56.7 Million USD | -29.21% |
| 2014 Q2 | 16.4 Million USD | 88.51% |
| 2013 FY | 80.1 Million USD | 3.35% |
| 2013 Q4 | 35.2 Million USD | 112.05% |
| 2013 Q3 | 16.6 Million USD | -27.51% |
| 2013 Q2 | 22.9 Million USD | 324.07% |
| 2013 Q1 | 5.4 Million USD | -57.81% |
| 2012 FY | 77.5 Million USD | -16.03% |
| 2012 Q1 | 15.1 Million USD | -61.38% |
| 2012 Q2 | 9.9 Million USD | -34.44% |
| 2012 Q3 | 39.7 Million USD | 301.01% |
| 2012 Q4 | 12.8 Million USD | -67.76% |
| 2011 FY | 92.3 Million USD | -3.25% |
| 2011 Q1 | 11.3 Million USD | -61.43% |
| 2011 Q3 | 19.8 Million USD | -10.41% |
| 2011 Q2 | 22.1 Million USD | 95.58% |
| 2011 Q4 | 39.1 Million USD | 97.47% |
| 2010 Q3 | 27.4 Million USD | 21.24% |
| 2010 Q2 | 22.6 Million USD | 40.37% |
| 2010 FY | 95.4 Million USD | 17.49% |
| 2010 Q4 | 29.3 Million USD | 6.93% |
| 2010 Q1 | 16.1 Million USD | -62.99% |
| 2009 Q1 | 8.2 Million USD | -68.53% |
| 2009 FY | 81.2 Million USD | 25.12% |
| 2009 Q4 | 43.5 Million USD | 165.24% |
| 2009 Q3 | 16.4 Million USD | 27.13% |
| 2009 Q2 | 12.9 Million USD | 57.32% |
| 2008 FY | 64.9 Million USD | 105.84% |
| 2008 Q4 | 26.05 Million USD | 46.4% |
| 2008 Q3 | 17.8 Million USD | -17.97% |
| 2008 Q2 | 21.7 Million USD | 3267.88% |
| 2008 Q1 | -685 Thousand USD | -104.89% |
| 2007 Q1 | 3.88 Million USD | -60.02% |
| 2007 Q2 | 4.96 Million USD | 27.93% |
| 2007 FY | 31.52 Million USD | 70.6% |
| 2007 Q3 | 8.66 Million USD | 74.5% |
| 2007 Q4 | 14.01 Million USD | 61.81% |
| 2006 Q2 | 480 Thousand USD | -38.14% |
| 2006 Q1 | 776 Thousand USD | -58.41% |
| 2006 FY | 18.48 Million USD | 406.88% |
| 2006 Q3 | 2.97 Million USD | 520.0% |
| 2006 Q4 | 9.7 Million USD | 226.21% |
| 2005 FY | 3.64 Million USD | 146.56% |
| 2005 Q2 | 284 Thousand USD | -31.89% |
| 2005 Q1 | 417 Thousand USD | 128.43% |
| 2005 Q3 | 1.07 Million USD | 279.93% |
| 2005 Q4 | 1.86 Million USD | 72.94% |
| 2004 Q1 | 1.03 Million USD | 233.23% |
| 2004 Q3 | -2.71 Million USD | 41.96% |
| 2004 Q4 | -1.46 Million USD | 46.01% |
| 2004 Q2 | -4.68 Million USD | -553.15% |
| 2004 FY | -7.83 Million USD | 55.39% |
| 2003 Q2 | -233 Thousand USD | 78.43% |
| 2003 Q1 | -1.08 Million USD | 76.63% |
| 2003 Q4 | 310 Thousand USD | 102.11% |
| 2003 Q3 | -14.66 Million USD | -6195.71% |
| 2003 FY | -17.55 Million USD | -183.13% |
| 2002 Q1 | 941 Thousand USD | 0.75% |
| 2002 FY | -6.2 Million USD | -270.47% |
| 2002 Q4 | -4.62 Million USD | -376.27% |
| 2002 Q3 | 1.67 Million USD | 139.91% |
| 2002 Q2 | -4.19 Million USD | -545.48% |
| 2001 Q1 | 945 Thousand USD | -23.17% |
| 2001 FY | 3.63 Million USD | 61.64% |
| 2001 Q4 | 934 Thousand USD | 0.97% |
| 2001 Q3 | 925 Thousand USD | 11.04% |
| 2001 Q2 | 833 Thousand USD | -11.85% |
| 2000 Q2 | 213 Thousand USD | 22.24% |
| 2000 Q1 | 174.24 Thousand USD | 0.0% |
| 2000 Q4 | 1.23 Million USD | 94.31% |
| 2000 Q3 | 633 Thousand USD | 197.18% |
| 2000 FY | 2.25 Million USD | 80.07% |
| 1999 FY | 1.24 Million USD | 0.0% |
| 1998 FY | - USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | -61.61 Million USD | 793.304% |
| BrainsWay Ltd. | -4.19 Million USD | 10278.699% |
| Cerus Corporation | -37.48 Million USD | 1239.534% |
| Envoy Medical, Inc. | -29.9 Million USD | 1528.38% |
| electroCore, Inc. | -18.83 Million USD | 2368.238% |
| Helius Medical Technologies, Inc. | -8.85 Million USD | 4927.119% |
| IceCure Medical Ltd | -14.65 Million USD | 3015.643% |
| Inogen, Inc. | -102.44 Million USD | 516.988% |
| OrthoPediatrics Corp. | -20.97 Million USD | 2136.807% |
| Lucid Diagnostics Inc. | -52.66 Million USD | 911.15% |
| Monogram Orthopaedics, Inc. | -13.74 Million USD | 3207.99% |
| MaxCyte, Inc. | -37.92 Million USD | 1226.493% |
| NeuroOne Medical Technologies Corporation | -11.85 Million USD | 3702.178% |
| Nexalin Technology, Inc. | -4.64 Million USD | 9289.648% |
| Orthofix Medical Inc. | -151.39 Million USD | 382.176% |
| PAVmed Inc | -64.17 Million USD | 765.68% |
| Rapid Micro Biosystems, Inc. | -52.46 Million USD | 914.226% |
| RxSight, Inc. | -48.6 Million USD | 978.868% |
| Sight Sciences, Inc. | -55.54 Million USD | 869.078% |
| SI-BONE, Inc. | -43.33 Million USD | 1085.785% |
| TELA Bio, Inc. | -46.66 Million USD | 1015.481% |
| Treace Medical Concepts, Inc. | -49.52 Million USD | 962.56% |
| Vivos Therapeutics, Inc. | -13.58 Million USD | 3245.108% |
| Acutus Medical, Inc. | -81.66 Million USD | 623.126% |
| Talis Biomedical Corporation | -62 Million USD | 788.954% |
| Spectral AI, Inc. | -20.85 Million USD | 2148.528% |
| Nano-X Imaging Ltd. | -60.77 Million USD | 802.909% |
| CVRx, Inc. | -41.19 Million USD | 1136.918% |
| DIH Holding US, Inc. Warrants | 640.19 Thousand USD | -66629.564% |
| PetVivo Holdings, Inc. | -10.95 Million USD | 3999.484% |
| Bioventus Inc. | -156.23 Million USD | 373.443% |
| Venus Concept Inc. | -37.25 Million USD | 1246.846% |
| TriSalus Life Sciences, Inc. | -59.03 Million USD | 823.602% |
| LivaNova PLC | 17.54 Million USD | -2334.743% |
| 908 Devices Inc. | -36.39 Million USD | 1273.659% |
| Alphatec Holdings, Inc. | -186.63 Million USD | 328.892% |
| Nemaura Medical Inc. | -14.14 Million USD | 3120.419% |
| NeuroPace, Inc. | -32.95 Million USD | 1396.274% |
| LENSAR, Inc. | -14.38 Million USD | 3070.173% |
| Apyx Medical Corporation | -18.71 Million USD | 2382.905% |
| Cutera, Inc. | -162.83 Million USD | 362.355% |
| STRATA Skin Sciences, Inc. | -10.83 Million USD | 4044.598% |
| BioSig Technologies, Inc. | -29.04 Million USD | 1571.024% |
| Anika Therapeutics, Inc. | -82.66 Million USD | 616.772% |
| ClearPoint Neuro, Inc. | -22.08 Million USD | 2033.994% |
| Integra LifeSciences Holdings Corporation | 67.74 Million USD | -530.637% |
| Axonics, Inc. | -6.08 Million USD | 7117.083% |
| Outset Medical, Inc. | -172.79 Million USD | 347.227% |
| IRIDEX Corporation | -9.57 Million USD | 4563.95% |
| PROCEPT BioRobotics Corporation | -105.89 Million USD | 503.411% |
| IRadimed Corporation | 17.19 Million USD | -2384.765% |
| Tivic Health Systems, Inc. | -8.24 Million USD | 5281.951% |
| INVO Bioscience, Inc. | -8.03 Million USD | 5416.996% |
| Telesis Bio, Inc. | -47.72 Million USD | 995.147% |
| Viemed Healthcare, Inc. | 10.24 Million USD | -4070.653% |
| Varex Imaging Corporation | -47.7 Million USD | 995.597% |
| Quipt Home Medical Corp. | -2.78 Million USD | 15444.828% |
| Inspira Technologies Oxy B.H.N. Ltd. | -11.28 Million USD | 3885.221% |
| Pulmonx Corporation | -60.84 Million USD | 802.135% |
| Dynatronics Corporation | -2.69 Million USD | 15935.6% |
| Modular Medical, Inc. | -17.47 Million USD | 2545.335% |
| ReShape Lifesciences Inc. | -11.38 Million USD | 3851.647% |
| Semler Scientific, Inc. | 20.58 Million USD | -1975.499% |
| InMode Ltd. | 197.91 Million USD | -115.846% |
| Cytosorbents Corporation | -28.5 Million USD | 1598.559% |
| DexCom, Inc. | 541.5 Million USD | 21.108% |
| Align Technology, Inc. | 445.05 Million USD | 4.011% |
| Viveve Medical, Inc. | -22.02 Million USD | 2039.438% |
| ZimVie Inc. | -393.28 Million USD | 208.624% |
| Movano Inc. | -29.28 Million USD | 1558.867% |
| Cytek Biosciences, Inc. | -12.14 Million USD | 3616.628% |
| Nexalin Technology, Inc. | -4.64 Million USD | 9289.648% |
| DIH Holdings US, Inc. Class A Common Stock | 640.19 Thousand USD | -66629.564% |
| Tandem Diabetes Care, Inc. | -222.61 Million USD | 291.904% |
| Profound Medical Corp. | -28.56 Million USD | 1595.327% |
| Insulet Corporation | 206.3 Million USD | -107.077% |
| enVVeno Medical Corporation | -23.51 Million USD | 1916.635% |
| Surmodics, Inc. | -11.54 Million USD | 3801.265% |
| iCAD, Inc. | -4.84 Million USD | 8913.699% |
| Nuwellis, Inc. | -20.2 Million USD | 2213.91% |
| Biotricity, Inc. | -14.09 Million USD | 3131.016% |
| iRhythm Technologies, Inc. | -123.4 Million USD | 446.174% |
| Aethlon Medical, Inc. | -12.2 Million USD | 3599.295% |
| InspireMD, Inc. | -19.91 Million USD | 2245.009% |
| PAVmed Inc. | -64.17 Million USD | 765.68% |
| BIOLASE, Inc. | -20.63 Million USD | 2170.57% |
| Beyond Air, Inc. | -60.24 Million USD | 809.14% |
| FONAR Corporation | 10.56 Million USD | -3942.623% |
| AxoGen, Inc. | -21.71 Million USD | 2067.213% |
| Vivani Medical, Inc. | -25.65 Million USD | 1765.367% |
| Tactile Systems Technology, Inc. | 28.51 Million USD | -1398.159% |
| Inari Medical, Inc. | -1.63 Million USD | 26212.469% |
| UFP Technologies, Inc. | 44.92 Million USD | -850.939% |
| QT Imaging Holdings, Inc. | -5.13 Million USD | 8423.702% |
| Heart Test Laboratories, Inc. | -6.6 Million USD | 6567.624% |
| Tenon Medical, Inc. | -15.58 Million USD | 2841.801% |
| Autonomix Medical, Inc. Common Stock | -15.42 Million USD | 2869.35% |
| Co-Diagnostics, Inc. | -35.33 Million USD | 1309.073% |
| AdaptHealth Corp. | -678.89 Million USD | 162.926% |
| Sintx Technologies, Inc. | -8.25 Million USD | 5272.539% |
| NanoVibronix, Inc. | -3.71 Million USD | 11611.722% |
| Quanterix Corporation | -32.33 Million USD | 1421.21% |
| Inspira Technologies Oxy B.H.N. Ltd. | -11.28 Million USD | 3885.221% |
| Sensus Healthcare, Inc. | 485 Thousand USD | -87982.474% |
| Pacific Biosciences of California, Inc. | -306.73 Million USD | 239.273% |
| TransMedics Group, Inc. | -25.02 Million USD | 1806.888% |
| ReWalk Robotics Ltd. | -22.13 Million USD | 2030.15% |
| NeuroMetrix, Inc. | -6.52 Million USD | 6642.627% |
| Hyperfine, Inc. | -44.23 Million USD | 1065.686% |
| Establishment Labs Holdings Inc. | -78.5 Million USD | 644.19% |
| Biomerica, Inc. | -5.97 Million USD | 7246.203% |
| Bone Biologics Corporation | -8.94 Million USD | 4873.861% |
| AVITA Medical, Inc. | -39.16 Million USD | 1190.68% |
| Bluejay Diagnostics, Inc. | -9.95 Million USD | 4391.79% |
| Silk Road Medical, Inc | -55.74 Million USD | 866.374% |